An experimental strategy unveiling exosomal microRNAs 486‐5p, 181a‐5p and 30d‐5p from hypoxic tumour cells as circulating indicators of high‐risk rectal cancer

Journal of extracellular vesicles - Tập 8 Số 1 - 2019
Tonje Bjørnetrø1,2, Kathrine Røe Redalen3,3, Sebastian Meltzer1,2, Nirujah Sivarajah Thusyanthan1, Rampradeep Samiappan4, Caroline Jegerschöld4, K. Risberg Handeland1, Anne Hansen Ree1,2
1Department of Oncology, Akershus University Hospital, Lørenskog, Norway
2Institute of Clinical Medicine, University of Oslo, Oslo, Norway
3Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway
4Department of Bioscience and Nutrition, Karolinska Institutet, Huddinge, Sweden

Tóm tắt

ABSTRACTTumour hypoxia contributes to poor treatment outcome in locally advanced rectal cancer (LARC) and circulating extracellular vesicles (EVs) as potential biomarkers of tumour hypoxia and adverse prognosis have not been fully explored. We examined EV miRNAs from hypoxic colorectal cancer cell lines as template for relevant miRNAs in LARC patients participating in a prospective biomarker study (NCT01816607). Five cell lines were cultured under normoxia (21% O2) or hypoxia (0.2% O2) for 24 h, and exosomes were isolated by differential ultracentrifugation. Using a commercial kit, exosomes were precipitated from 24 patient plasma samples collected at the time of diagnosis. Exosome size distribution and protein cargo were determined by cryo‐electron microscopy, nanoparticle tracking analysis, immunoblotting and flow cytometry. The vesicles harboured strong cell line‐specific miRNA profiles with 35 unique miRNAs differentially expressed between hypoxic and normoxic cells. Six of these miRNAs were considered candidate‐circulating markers of tumour hypoxia in the patients based on the frequency or magnitude of variance in hypoxic versus normoxic cell line experiments and prevalence in patient plasma. Of these, low plasma levels of exosomal miR‐486‐5p and miR‐181a‐5p were associated with organ‐invasive primary tumour (p = 0.029) and lymph node metastases (p = 0.024), respectively, both attributes of adverse LARC prognosis. In line with this, the plasma level of exosomal miR‐30d‐5p was elevated in patients who experienced metastatic progression (p = 0.036). Our strategy confirmed that EVs from colorectal cancer cell lines were exosomes containing the oxygen‐sensitive miRNAs 486‐5p, 181a‐5p and 30d‐5p, which were retrieved as circulating markers of high‐risk LARC.

Từ khóa


Tài liệu tham khảo

10.1016/j.semcdb.2005.03.007

10.1038/nrc704

10.1038/nrc3261

10.5507/bp.2015.025

10.1016/j.pharmthera.2016.04.009

10.1111/joim.12393

10.1186/1471-2407-12-421

10.1074/mcp.M900381-MCP200

10.1038/sigtrans.2015.4

10.1155/2015/125094

10.1016/j.freeradbiomed.2013.05.022

10.1038/aps.2012.195

10.1586/14737159.2016.1156535

10.3389/fphar.2017.00583

10.1016/j.clcc.2017.06.008

10.1016/S1470-2045(13)70599-0

Glimelius B, 2013, Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up, Ann Oncol, 24, 81, 10.1093/annonc/mdt240

Glynne‐Jones R, 2017, Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up, Ann Oncol, 28, 22, 10.1093/annonc/mdx224

10.1097/DCR.0b013e31825bd80c

10.1038/bjc.2015.93

10.1002/bjs.9192

10.3402/jev.v2i0.20677

10.1186/gb-2009-10-6-r64

10.1038/nrclinonc.2011.118

10.3748/wjg.v22.i5.1745

10.1038/srep31175

10.3402/jev.v3.25011

Witwer KW, 2013, Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, J Extracell Vesicles, 2, 10.3402/jev.v2i0.20360

10.1371/journal.pone.0170628

10.3402/jev.v5.31488

10.18632/oncotarget.15059

10.1371/journal.pone.0092921

10.1093/hmg/ddx059

10.1053/j.gastro.2012.04.009

10.1371/journal.pone.0158537

10.1016/j.bbrc.2013.03.054

10.1007/s00210-012-0808-1

10.1016/j.yexcr.2017.09.009

10.1042/CS20140012

Hill AF, 2013, ISEV position paper: extracellular vesicle RNA analysis and bioinformatics, J Extracell Vesicles, 2

Liu C, 2016, miR‐486‐5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin‐2 in colorectal carcinoma, Onco Targets Ther, 9, 2865

10.1038/onc.2013.42

10.1158/1078-0432.CCR-10-3152

10.1016/j.bbrc.2016.01.084

10.1016/j.yexcr.2016.12.023

10.2217/bmm-2016-0222

10.1158/0008-5472.CAN-14-2875

10.1186/s12943-017-0583-1

10.1002/hep.23443

10.1089/omi.2010.0098

10.1177/1010428317695932

10.1038/nrc.2017.6